Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Sequent Scientific Limited
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

Get this company's details upto March 2024. FREE access. Sign up now!

SEQUENT SCIENTIFIC LIMITED

www.sequent.in

All Companies ›

Maharashtra ›

Active

Updated: 18 Apr 2025

Sequent Scientific Limited, is an unlisted public company incorporated on 28 June, 1985. It is classified as a public limited company and is located in Thane West, Maharashtra. It's authorized share capital is INR 80.00 cr and the total paid-up capital is INR 49.92 cr.

Sequent Scientific Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's book networth has increased by 1.66%.

Subscription Plans

Industry and products

Community, Personal and Social Services

Analytical Solutions, Albendazole, Alivira Animal Health, Human Health Service, Artesunate, Aciclovir Sodium, Artemether

Company size

Auth Capital

₹ 80.0 Cr

Paidup Capital

₹ 49.9 Cr

Revenue

₹ 200-300 cr

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue

-14.52%

₹ GET PRO

EBITDA

₹ GET PRO

Net Profit

₹ GET PRO

Networth

2.73%

₹ GET PRO

Borrowings

143.23%

₹ GET PRO

Assets

5.77%

₹ GET PRO

Gross Margin

-2.99

GET PRO %

Operating Margin

-3.98

GET PRO %

Net Profit Margin

2.71

GET PRO %

Return on Equity

0.63

GET PRO %

ROCE

-27.89

GET PRO %

Debt to Equity

0.02

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (7)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Milind Shripad Sarwate	00109854	5 years
Director	Kamal Kishore Sharma	00209430	5 years
Director	Hari Babu Bodepudi	01119687	2 years
Director	Neeraj Bharadwaj	01314963	5 years
Director	Rajaram Narayanan	02977405	3 years
Kmp	Phillip Trott	<HIDDEN>	1 years
Director	Kausalya Santhanam	06999168	11 years
Director	Gregory John Andrews	08904518	5 years
Director	Fabian Martin Kausche	08976500	5 years
Director	Vedprakash Shantalingappa Ragate	10578409	1 years
Kmp	Saurav Bhala	<HIDDEN>	2 years

Financial Highlights

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2024 available in Tofler Pro

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	49.7	49.7	49.7	49.9	49.9
Reserves	737.8	726.6	690.7	699.3	663.1
Borrowings +	284.4	196.6	314.9	397.9	451.3
Long term borrowings	150.1	93.7	122.5	182.8	142.7
Short term borrowings	134.4	102.9	192.4	215.1	308.6
Trade payables +	220.4	229.6	258.0	244.3	260.3
Days payable	133.0	121.0	119.0	107.0	125.0
Other liabilities +	446.4	419.6	386.2	382.0	376.1
Other non-current liabilities	111.1	61.6	66.5	71.1	57.7
Other current liabilities	114.9	128.4	61.6	66.6	58.2
Total liabilities	1,518.3	1,392.6	1,441.5	1,529.1	1,540.4
Fixed Assets +	645.6	566.4	566.6	660.6	607.9
Tangible assets	344.9	319.1	316.5	300.7	300.1
CWIP	13.4	29.8	11.6	55.3	15.9
Intangible assets	287.3	217.5	238.4	304.6	291.8
LT loans and advances	-	-	-	-	-
Other non-current assets	168.5	112.5	88.2	88.7	121.6
Current assets +	704.1	713.6	786.7	779.8	810.9
Inventories	219.4	264.4	348.0	346.1	346.2
Trade receivables	318.8	346.1	329.2	341.0	335.6
Cash and cash equivalents	68.1	53.7	57.5	41.6	64.8
ST loans and advances	0.3	0.2	0.3	0.3	0.1
Other current assets	97.5	49.2	51.7	50.8	64.1
Total assets	1,518.3	1,392.6	1,441.5	1,529.1	1,540.4

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	3.27	3.57	3.45	3.26	3.24
Reserves	48.6	52.18	47.92	45.73	43.05
Borrowings +	18.73	14.12	21.84	26.02	29.3
Long term borrowings	9.88	6.73	8.49	11.95	9.27
Short term borrowings	8.85	7.39	13.35	14.07	20.03
Trade payables	14.51	16.49	17.9	15.98	16.9
Other liabilities +	29.4	30.13	26.79	24.98	24.42
Other non-current liabilities	7.32	4.43	4.61	4.65	3.75
Other current liabilities	7.57	9.22	4.28	4.36	3.78
Total liabilities
Fixed Assets +	42.52	40.68	39.31	43.2	39.46
Tangible assets	22.72	22.91	21.96	19.67	19.49
CWIP	0.88	2.14	0.81	3.62	1.03
Intangible assets	18.92	15.62	16.54	19.92	18.94
LT loans and advances	0.0	0.0	0.0	0.0	0.0
Other non-current assets	11.1	8.08	6.12	5.8	7.89
Current assets +	46.38	51.24	54.58	51.0	52.65
Inventories	14.45	18.98	24.14	22.63	22.48
Trade receivables	20.99	24.86	22.84	22.3	21.79
Cash and cash equivalents	4.49	3.86	3.99	2.72	4.21
ST loans and advances	0.02	0.01	0.02	0.02	0.01
Other current assets	6.42	3.53	3.59	3.32	4.16
Total assets

Total assets

Charges on assets

Bank wise

Charges

Catalyst Trusteeship Limited

No. of Loans: 1

Total Amount : 360.0 cr

ICICI Bank Limited

No. of Loans: 1

Total Amount : 38.0 cr

Aditya Birla Finance Limited

No. of Loans: 2

Total Amount : 25.0 cr

Charge Holder	Amount	Date of creation/modification
Catalyst Trusteeship Limited	360.0 cr	08 Apr, 2024
Aditya Birla Finance Limited	15.0 cr	27 Dec, 2023
Aditya Birla Finance Limited	10.0 cr	27 Dec, 2023
ICICI Bank Limited	38.0 cr	03 Feb, 2022

Charges

Catalyst Trusteeship Limited

ICICI Bank Limited

Aditya Birla Finance Limited

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
HALITE PERSONAL CARE INDIA PRIVATE LIMITED	Under Liquidation	91.9 L	1	Maharashtra
INCREATE FOUNDATION	Active	5.0 L	1	Maharashtra
INCREATE SOCIAL VALUE ADVISORS & RESOURCERS LLP	Active	1.0 L	1	Maharashtra
INCREATE VALUE ADVISORS LLP	Active	1.0 L	1	Maharashtra
HEXAWARE TECHNOLOGIES LIMITED	Active	60.7 Cr	2	Maharashtra
WHEELSEMI PRIVATE LIMITED	Active	50.1 Cr	1
FSN E-COMMERCE VENTURES LIMITED	Active	286.0 Cr	1
MAHINDRA AND MAHINDRA FINANCIAL SERVICES LIMITED	Active	278.0 Cr	1
OMNIACTIVE HEALTH TECHNOLOGIES LIMITED	Active	11.7 Cr	1
GEOMETRIC LIMITED	Amalgamated	13.4 Cr	1
ASIAN PAINTS LIMITED	Active	95.9 Cr	1
CEAT LIMITED	Active	40.5 Cr	1
LUPIN PHARMACARE LIMITED	Amalgamated	1.1 Cr	1	Maharashtra
TEMPLECRAFT REALTY LLP	Active	1.0 L	1	Maharashtra
TEMPLERIVIERE PROPERTY LLP	Active	1.0 L	1	Maharashtra
TEMPLE WELLNESS VENTURES LLP	Active	1.0 L	1	Maharashtra
TEMPLETREE PROPERTIES PRIVATE LIMITED	Active	10.0 L	1	Maharashtra
VIYASH LIFE SCIENCES PRIVATE LIMITED	Active	334.4 Cr	3	Telangana
FAISA FINANCIAL P LTD	Active	52.0 L	1	Maharashtra
TEMPLE WELLNESS VENTURES INDIA PRIVATE LIMITED	Active	10.0 L	1	Maharashtra
SHILPA MEDICARE LIMITED	Active	9.8 Cr	1
SYMED LABS LIMITED	Active	93.0 L	2
ALIVIRA ANIMAL HEALTH LIMITED	Active	47.8 Cr	3
ASTRIX LABORATORIES LIMITED	Amalgamated	4.5 Cr	1	Telangana
VINDHYA PHARMA (INDIA) PRIVATE LIMITED	Active	1.9 Cr	1	Telangana
VIYASH LABORATORIES PRIVATE LIMITED	Strike Off	10.0 L	1	Telangana
VIYASH PHARMACEUTICALS PRIVATE LIMITED	Strike Off	10.0 L	1	Telangana
APPCURE LABS PRIVATE LIMITED	Active	51.8 L	1	Telangana
FOUNDATION FOR PROMOTION OF SPORTS AND GAMES	Active	1.0 L	1	Maharashtra
PIRAMAL PHARMA LIMITED	Active	1,322.9 Cr	1	Maharashtra
ACCEL INDIA GROWTH MANAGEMENT COMPANY PR IVATE LIMITED	Strike Off	1.0 L	1	Delhi
GOLWILKAR METROPOLIS HEALTH SERVICES (INDIA) PRIVATE LIMITED	Amalgamated	10.0 L	1	Maharashtra
INDEGENE LIMITED	Active	47.9 Cr	1	Karnataka
NXTRA DATA LIMITED	Active	11.9 Cr	1	Delhi
INDIAN SCHOOL OF BUSINESS	Active	0.0	1	Telangana
PIRAMAL PHARMA LIMITED	Active	1,322.9 Cr	1	Maharashtra
VER SE INNOVATION PRIVATE LIMITED	Active	11.7 Cr	1
VISIONARY RCM INFOTECH (INDIA) PRIVATE LIMITED	Amalgamated	3.7 Cr	1
VLCC LIMITED	Active	44.2 Cr	1
GENZYME INDIA PRIVATE LIMITED	Amalgamated	9.2 Cr	1	Maharashtra
SANOFI ANIMAL HEALTH INDIA PRIVATE LIMITED	Strike Off	4.2 Cr	1	Maharashtra
SANOFI-SYNTHELABO (INDIA) PRIVATE LIMITED	Amalgamated	33.4 Cr	1	Maharashtra
SEQUENT RESEARCH LIMITED	Active	4.4 Cr	2	Karnataka
DESH SEVA SAMITI	Active	0.0	1	Maharashtra
SOLARA ACTIVE PHARMA SCIENCES LIMITED	Active	44.3 Cr	1
STRIDES PHARMA SCIENCE LIMITED	Active	92.2 Cr	1

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
ALIVIRA ANIMAL HEALTH LIMITED		2013	₹ 47.8 Cr

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

L99999MH1985PLC036685

PAN

AAACV1501G

Incorporation

1985, 40.0 years

Company Email

investorrelations@sequent.in

Paid up Capital

₹ 49.9 Cr

Authorised Capital

₹ 80.0 Cr

AGM

Aug 2023

Type

Public

Non-government Company

FAQ - SEQUENT SCIENTIFIC LIMITED

What is the incorporation date of SEQUENT SCIENTIFIC LIMITED?

The incorporation date of SEQUENT SCIENTIFIC LIMITED is 28 June, 1985

What is the authorized share capital of SEQUENT SCIENTIFIC LIMITED?

The authorized share capital of SEQUENT SCIENTIFIC LIMITED is INR ₹ 80.0 Cr.

What is the paid-up capital of SEQUENT SCIENTIFIC LIMITED?

The paid-up capital of SEQUENT SCIENTIFIC LIMITED is INR ₹ 49.9 Cr.

What is the registered address of SEQUENT SCIENTIFIC LIMITED?

The registered address of SEQUENT SCIENTIFIC LIMITED is 301, 3rd Floor, Dosti Pinnacle, Plot No.E7 Road No.22, Wag le Industrial Estate, NA Thane west Maharashtra - 400604

What is the CIN number of SEQUENT SCIENTIFIC LIMITED?

The CIN number of SEQUENT SCIENTIFIC LIMITED is L99999MH1985PLC036685.

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

SEQUENT SCIENTIFIC LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Charges on assets

Charges

Company Network